Helping You Build Wealth With Honest Research
Since 1996. Try Now

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

NURECA Fact Sheet  (NRCA)



For You: Midcap Stocks Research at Less than Its Launch Price


Here is the latest financial fact sheet of NURECA. For more details, see the NURECA quarterly results and NURECA share price. For a sector overview, read our pharmaceuticals sector report.

NURECA Price History

Price Rs 282.3
Mkt Cap Rs m 2,823
Vol '000 4.8
P/E X 343.4
P/CF X -48.2
EPS (TTM) Rs 0.8
1 Day % 1.5
No. of shares m 10.00
1 Week % -2.6
1 Month % -8.8
1 Year % -16.7
52 week H/L Rs 468.3/252.4
As on Apr 16, 2024 (Close)
* Results Consolidated
Excel EXPORT | DO YOU LIKE THESE FACTSHEETS? TELL US!

NURECA Financials

No. of Mths
Year Ending
12
Mar-19
*
12
Mar-20
*
12
Mar-21
*
12
Mar-22
*
12
Mar-23
*
5-Yr Chart
Click to enlarge
NURECA EQUITY SHARE DATA
High RsNANA7602,3171,448 
Low RsNANA559589294 
Sales per share (Unadj.) Rs61,897.099,426.0213.5255.5111.3 
Earnings per share (Unadj.) Rs6,226.06,395.046.445.0-8.3 
Diluted earnings per shareRs6.26.446.445.0-8.2 
Cash flow per share (Unadj.) Rs6,283.06,769.046.846.4-5.9 
Dividends per share (Unadj.) Rs002.003.000 
Adj. dividends per shareRs0.000.002.003.000.00 
Avg Dividend yield %000.30.20 
Book value per share (Unadj.) Rs6,955.013,935.0163.1203.2194.9 
Adj. book value per shareRs7.013.9163.1203.2194.9 
Shares outstanding (eoy) m0.010.0110.0010.0010.00 
Bonus / Rights / Conversions  00000 
Price / Sales ratio x003.15.77.8 
Avg P/E ratio x0014.232.3-105.6 
P/CF ratio (eoy) x0014.131.3-148.6 
Price / Book Value ratio x004.07.14.5 
Dividend payout %004.36.70 
Avg Mkt Cap Rs m006,59614,5268,710 
No. of employees `000NANANANANA 
Total wages/salary Rs m9324699161 
Avg. sales/employee Rs Th00000 
Avg. wages/employee Rs Th00000 
Avg. net profit/employee Rs Th00000 
NURECA INCOME DATA
Net Sales Rs m6199942,1352,5551,113 
Other income Rs m11287771 
Total revenues Rs m6209952,1632,6321,184 
Gross profit Rs m9197615555-150 
Depreciation Rs m1441524 
Interest Rs m281675 
Profit before tax Rs m8886623610-107 
Minority Interest Rs m00000 
Prior Period Items Rs m00000 
Extraordinary Inc (Exp) Rs m00000 
Tax Rs m2622160160-25 
Profit after tax Rs m6264464450-83 
Gross profit margin %14.69.728.821.7-13.5 
Effective tax rate %29.625.725.626.323.2 
Net profit margin %10.16.421.717.6-7.4 
NURECA BALANCE SHEET DATA
Current assets Rs m2303281,8622,3921,866 
Current liabilities Rs m1539523945389 
Net working cap to sales %12.423.476.075.9159.6 
Current ratio x1.53.47.85.320.9 
Inventory Days Days00051222 
Debtors Days Days52470414 
Net fixed assets Rs m51141128173 
Share capital Rs m00100100100 
"Free" reserves Rs m691391,5311,9321,849 
Net worth Rs m701391,6312,0321,949 
Long term debt Rs m393800 
Total assets Rs m2353381,9032,5212,039 
Interest coverage x37.412.139.983.3-22.9 
Debt to equity ratio x00.7000 
Sales to assets ratio x2.62.91.11.00.5 
Return on assets %27.521.225.218.1-3.8 
Return on equity %89.545.928.422.1-4.2 
Return on capital %125.940.339.030.4-5.3 
Exports to sales %00000 
Imports to sales %00000 
Exports (fob) Rs m00000 
Imports (cif) Rs m00000 
Fx inflow Rs m00000 
Fx outflow Rs m0001,160230 
Net fx Rs m000-1,160-230 
NURECA CASH FLOW
From Operations Rs m 3 -79 349 14 102 
From Investments Rs m -1 -4 -1,100 -31 -165 
From Financial Activity Rs m -1 83 923 -73 -15 
Net Cashflow Rs m 0 -0 172 -90 -77 
* Results Consolidated
Source: Accord Fintech, Equitymaster

Share Holding

Promoters 63.2%
Institution 0.1%
Non-Institution 36.7%
Total 100.0%
Free Float 36.8%
Pledged promoter holdings 0.0%
Shareholding as on Mar 2024
 

Company Information

Regd Off Office No. 101 1st Floor, Udyog Bhavan Sonawala Lane, Goregaon East, Mumbai - 400063
E-mail cs@nureca.com Web www.nureca.com
Tel 0172-5292900 Fax
Sector MEDICAL EQUIPMENT/SUPPLIES/ACCESSORIES Group Private sector
Tr Agent Alankit Assignments Ltd., 205-208 Anarkali Complex, Jhandewala Extension
CHM: Saurabh Goyal COMP SEC: Chetna Anand YEAR OF INC: 2016 BSE CODE: 543264 FV (Rs): 10 DIV YIELD (%): -

Read: NURECA 2022-23 Annual Report Analysis

More Medical Equipment/supplies/accessories Company Fact Sheets:   DIVIS LABORATORIES    DR. REDDYS LAB    ZYDUS LIFESCIENCES    SUN PHARMA    CIPLA    

Compare NURECA With:   DIVIS LABORATORIES    DR. REDDYS LAB    ZYDUS LIFESCIENCES    SUN PHARMA    CIPLA    




Today's Market

Sensex Today Ends 456 Points Lower | IT Stocks Drag | 5 Reasons Why Indian Share Market is Falling Sensex Today Ends 456 Points Lower | IT Stocks Drag | 5 Reasons Why Indian Share Market is Falling(Closing)

After opening the negative note, Indian share markets Slipped further as the session progressed and ended the day weak.